Compare · ICL vs NITO
ICL vs NITO
Side-by-side comparison of ICL Group Ltd. (ICL) and N2OFF Inc. (NITO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICL and NITO operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- ICL carries a market cap of $7.90B.
- Over the past year, ICL is down 12.2% and NITO is down 87.5% - ICL leads by 75.2 points.
- ICL has hit the wire 9 times in the past 4 weeks while NITO has been quiet.
- ICL has more recent analyst coverage (7 ratings vs 0 for NITO).
- Company
- ICL Group Ltd.
- N2OFF Inc.
- Price
- $6.13-1.45%
- $1.25+32.98%
- Market cap
- $7.90B
- -
- 1M return
- +10.85%
- -15.54%
- 1Y return
- -12.24%
- -87.48%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- News (4w)
- 9
- 0
- Recent ratings
- 7
- 0
ICL Group Ltd.
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts potash from the Dead Sea; mines and produces potash and salt; produces Polysulphate; produces, markets, and sells magnesium and magnesium alloys, as well as related by-products, including chlorine and sylvinite; and sells salt. The Phosphate Solutions segment uses phosphate commodity products to produce specialty products; produces and markets phosphate-based fertilizers, as well as sulphuric acid, green phosphoric acid, and phosphate fertilizers; and manufactures thermal phosphoric acid for various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. It also develops and produces functional food ingredients and phosphate additives for use in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets; and produces milk and whey proteins for the food ingredients industry. The IAS segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water soluble specialty, liquid, soluble, and controlled-release fertilizers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. ICL Group Ltd was founded in 1968 and is headquartered in Tel Aviv, Israel.
Latest ICL
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 3 filed by new insider Kilstein Alegra
- SEC Form 6-K filed by ICL Group Ltd.
- ICL Group Announces Launch of Senior Notes Offering
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 6-K filed by ICL Group Ltd.
- ICL Reports First Quarter 2026 Results
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 6-K filed by ICL Group Ltd.
Latest NITO
- SEC Form PRE 14A filed by N2OFF Inc.
- N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- N2OFF Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
- MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases
- Chief Executive Officer Palach David was granted 100,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Controller Zakai Shlomo was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Director Weiss Amitay was granted 116,286 units of Restricted Shares of Common Stock (SEC Form 4)
- Chief Financial Officer Barda Lital was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- In Spaceflight Conditions: N2OFF's MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions